Statistik Asas
| LEI | R05X5UQ874RGFF7HHD84 |
| CIK | 1056288 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Federated Hermes, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| July 31, 2025 |
MEDIA: ANALYSTS: Ed Costello 412-288-7538 Ray Hanley 412-288-1920 Exhibit 99.1 Federated Hermes, Inc. reports record assets under management with second quarter 2025 earnings •Total assets under management reach a record $845.7 billion •MDT strategies reach $23.2 billion, up $6.4 billion from Q1 2025 and up $8.9 billion YTD •Q2 2025 earnings per diluted share of $1.16 •Board declares $0.34 per share dividend and authorizes new share repurchase program (PITTSBURG |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 24, 2025 |
MEDIA: ANALYSTS: Ed Costello 412-288-7538 Ray Hanley 412-288-1920 Exhibit 99.1 Federated Hermes, Inc. reports record assets under management with first quarter 2025 earnings •Total assets under management reach a record $839.8 billion •Money market assets reach a record $637.1 billion •Q1 2025 earnings per diluted share of $1.25 •Quarterly dividend increased by 9.7% to $0.34 per share (PITTSBURGH, Pa., April 24, 2025) — Federated Hermes, Inc. (NYSE: FHI), a glob |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2025 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2025 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement FEDERATED HERMES, I |
|
| February 28, 2025 |
Exhibit 10.154 FEDERATED HERMES, INC. Stock Incentive Plan BONUS RESTRICTED STOCK PROGRAM AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, made this 5th day of March, 2025 by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania, A N D , an |
|
| February 28, 2025 |
EXHIBIT 31.01 CERTIFICATIONS I, J. Christopher Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 28, 2025 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 23.01 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-262085, No. 333-224540, No. 333-173859 and No. 333-136081) pertaining to the Federated Hermes, Inc. Stock Incentive Plan and the Registration Statement (Form S-8 No. 333-56429) pertaining to the Federated Hermes, Inc. Employee Stock P |
|
| February 28, 2025 |
FEDERATED HERMES, INC. POLICY ON TRADING AND CONFIDENTIALITY Exhibit 19.01 FEDERATED HERMES, INC. POLICY ON TRADING AND CONFIDENTIALITY SUMMARY The following is a summary of Federated Hermes, Inc.’s (including its domestic and offshore subsidiaries, “Federated Hermes”) Policy on Trading and Confidentiality (“Policy”) and should not be used as a substitute for carefully reviewing the Policy itself. Why do we have this Policy? The federal securities laws make |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14818 FEDERATED HERMES, INC. (Ex |
|
| February 28, 2025 |
EXHIBIT 31.02 CERTIFICATIONS I, Thomas R. Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with res |
|
| February 28, 2025 |
Exhibit 10.155 Federated Hermes Co- Investment Scheme Rules 2024 Adopted by the Remuneration Assurance Committee on 18 January 2024 Exhibit 10.155 Contents 1. Eligibility, Nature of Scheme and Definitions 1 2. Other Definitions 6 3. Participation Criteria & Selection of Funds 7 Selection of Funds by Investment Professionals 8 Selection of Funds for Non-Investment Professionals 8 No change of inves |
|
| February 28, 2025 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Federated Hermes, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities a |
|
| February 28, 2025 |
List of Domestic and Offshore Subsidiaries of Federated Hermes, Inc. – as of December 31, 2024 Exhibit 21.01 List of Domestic and Offshore Subsidiaries of Federated Hermes, Inc. – as of December 31, 2024 EMPEF GP Limited, Guernsey company Federated Administrative Services, a Delaware statutory trust Federated Administrative Services, Inc., a Pennsylvania corporation Federated Advisory Services Company, a Delaware statutory trust Federated Equity Management Company of Pennsylvania, Delaware |
|
| January 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2025 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| January 30, 2025 |
MEDIA: ANALYSTS: Ed Costello 412-288-7538 Ray Hanley 412-288-1920 Exhibit 99.1 Federated Hermes, Inc. reports record assets under management with fourth quarter and full-year 2024 earnings •Q4 2024 earnings per diluted share of $1.04; full-year 2024 EPS of $3.23 •Total assets under management at record $829.6 billion •Board declares $0.31 per share quarterly dividend (PITTSBURGH, Pa., Jan. 30, 2025) — Federated Hermes, Inc. (NYSE: FHI), a global leader in active |
|
| January 8, 2025 |
ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person IDENTITY CLASSIFICATION UNDER ITEM 3 Federated Hermes Equity Funds (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U. |
|
| January 8, 2025 |
EXHIBIT “3” POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints J. |
|
| January 8, 2025 |
EXHIBIT “3” POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints J. |
|
| January 8, 2025 |
EXHIBIT “3” POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints J. |
|
| January 8, 2025 |
AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G The following parties hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached and any amendments thereto which may be deemed necessary pursuant to Regulation 13D-G under the Securities Exchange Act of 1934: 1. |
|
| January 8, 2025 |
EXHIBIT “3” POWER OF ATTORNEY Each person whose signature appears below constitutes and appoints J. |
|
| January 8, 2025 |
ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person IDENTITY CLASSIFICATION UNDER ITEM 3 Federated Hermes Adviser Series (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U. |
|
| January 8, 2025 |
AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G The following parties hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached and any amendments thereto which may be deemed necessary pursuant to Regulation 13D-G under the Securities Exchange Act of 1934: 1. |
|
| November 6, 2024 |
EYPT / EyePoint Pharmaceuticals, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G 1 eyepointpharmaceuticals13g.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) EYEPOINT PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 30233G209 (CUSIP Number) October 31, 20 |
|
| November 6, 2024 |
SCYX / SCYNEXIS, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 scynexisamend13.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292200 (CUSIP Number) October 31, 2024 (Date of Event Which |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 24, 2024 |
MEDIA: ANALYSTS: Ed Costello 412-288-7538 Ray Hanley 412-288-1920 Exhibit 99.1 Federated Hermes, Inc. reports record assets under management with third quarter 2024 earnings •Total assets under management reach a record $800.5 billion •Money market assets at record $593.0 billion; fixed income assets at record $100.2 billion •Q3 2024 earnings per diluted share of $1.06 •Board declares $0.31 per share dividend; authorizes new share repurchase program (PITTSBURGH, |
|
| October 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2024 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| October 7, 2024 |
SDHC / Smith Douglas Homes Corp. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) SMITH DOUGLAS HOMES CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 83207R107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of |
|
| October 7, 2024 |
ATYR / aTyr Pharma, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8*) ATYR PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 002120202 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this St |
|
| October 7, 2024 |
SCYX / SCYNEXIS, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292200 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Stat |
|
| September 9, 2024 |
DVAX / Dynavax Technologies Corporation / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 24*) DYNAVAX TECHNOLOGIES CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 268158201 (CUSIP Number) August 31, 2024 (Date of Event Which Requires Fili |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2024 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| July 25, 2024 |
MEDIA: ANALYSTS: Ed Costello 412-288-7538 Ray Hanley 412-288-1920 Exhibit 99.1 Federated Hermes, Inc. reports record assets under management with second quarter 2024 earnings •Total assets under management reach a record $782.7 billion •Money market assets reach a record $586.6 billion •Q2 2024 earnings per diluted share of $0.20, including a ($0.76) per diluted share non-cash intangible asset impairment charge •Board declares $0.31 per share dividend (PITTSBURG |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 25, 2024 |
Exhibit 99.1 Federated Hermes, Inc. reports first quarter 2024 earnings of $0.89; Board declares cash dividend of $1.31 ($0.31 quarterly and $1.00 special) •Total assets under management reach a record $778.7 billion •Money market assets reach a record $578.8 billion •Q1 2024 earnings per diluted share of $0.89 •Quarterly dividend increased by 10.7% to $0.31 •Special dividend of $1.00 is the sixth |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| April 8, 2024 |
Fusion Networks Holdings, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) FUSION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36118A100 (CUSIP Number) March 31, 2024 (Date of Event Which Requires Filing of |
|
| March 25, 2024 |
Fusion Networks Holdings, Inc. / FEDERATED HERMES, INC. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* FUSION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36118A100 (CUSIP Number) STEPHEN VAN METER, CHIEF COMPLIANCE OFFICER FEDERATED HERMES, INC. FEDERATED HERMES TOWER 1001 LIBERTY AVENUE PITTSBURGH, PA 15222-3779 1-41 |
|
| March 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement FEDERATED HERMES, I |
|
| March 11, 2024 |
FHI / Federated Hermes, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Federated Hermes, Inc. Class B Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: February 29, 2024 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| March 6, 2024 |
AMPH / Amphastar Pharmaceuticals, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form1677.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) AMPHASTAR PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03209R103 (CUSIP Number) February 29, 2024 (Date of E |
|
| March 6, 2024 |
MRUS / Merus N.V. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 merus1678.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6*) MERUS, N.V. (Name of Issuer) COMMON STOCK (Title of Class of Securities) N5749R100 (CUSIP Number) February 29, 2024 (Date of Event Which Requires |
|
| February 23, 2024 |
Ex. 10.153 FEDERATED HERMES, INC. Stock Incentive Plan BONUS RESTRICTED STOCK PROGRAM AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, made this [ ] day of March, [ ] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania, AND [Name of Emp |
|
| February 23, 2024 |
List of Domestic and Offshore Subsidiaries of Federated Hermes, Inc. – as of December 31, 2023 Exhibit 21.01 List of Domestic and Offshore Subsidiaries of Federated Hermes, Inc. – as of December 31, 2023 EMPEF GP Limited, Guernsey company Federated Administrative Services, a Delaware statutory trust Federated Administrative Services, Inc., a Pennsylvania corporation Federated Advisory Services Company, a Delaware statutory trust Federated Equity Management Company of Pennsylvania, Delaware |
|
| February 23, 2024 |
EXHIBIT 31.01 CERTIFICATIONS I, J. Christopher Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14818 FEDERATED HERMES, INC. (Ex |
|
| February 23, 2024 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 23.01 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-262085, No. 333-224540, No. 333-173859 and No. 333-136081) pertaining to the Federated Hermes, Inc. Stock Incentive Plan and the Registration Statement (Form S-8 No. 333-56429) pertaining to the Federated Hermes, Inc. Employee Stock P |
|
| February 23, 2024 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Federated Hermes, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities a |
|
| February 23, 2024 |
Ex. 14.04 CODE OF ETHICS FOR SENIOR FINANCIAL OFFICERS Federated Hermes, Inc. Code of Ethics for Senior Financial Officers Pursuant to the Sarbanes-Oxley Act, the Board of Directors (“Board”) of Federated Hermes, Inc. (including its domestic and offshore subsidiaries, “Federated Hermes”) has adopted the following Code of Ethics, governing the conduct of the principal executive officer, the princip |
|
| February 23, 2024 |
FEDERATED HERMES, INC. Stock Incentive Plan BONUS RESTRICTED STOCK PROGRAM AWARD AGREEMENT Exhibit 10.152 FEDERATED HERMES, INC. Stock Incentive Plan BONUS RESTRICTED STOCK PROGRAM AWARD AGREEMENT THIS AGREEMENT, made this [ ] of March [ ] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania, AND [Name], an employee of the Company (the "Participant"). Cap |
|
| February 23, 2024 |
FEDERATED HERMES, INC. Incentive Compensation Recovery Policy Ex. 10.151 FEDERATED HERMES, INC. Incentive Compensation Recovery Policy 1. Purpose As required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, which added Section 10D to the Securities Exchange Act of 1934, as amended (“Exchange Act”), the U.S. Securities and Exchange Commission (“SEC”) through the promulgation of Rule 10D-1 under the Exchange Act (“Rule 10D-1”), and the |
|
| February 23, 2024 |
ELEVENTH AMENDMENT TO AGREEMENT OF LEASE Exhibit 10.150 ELEVENTH AMENDMENT TO AGREEMENT OF LEASE THIS ELEVENTH AMENDMENT TO AGREEMENT OF LEASE (this “Eleventh Amendment”) dated effective as of the 21st day of February 2023 (the “Effective Date”), is entered into by and between SPUS8 LIBERTY CENTER, LP, a Delaware limited partnership (the “Landlord”) and FEDERATED HERMES, INC., a Pennsylvania corporation formerly known as Federated Invest |
|
| February 23, 2024 |
EXHIBIT 31.02 CERTIFICATIONS I, Thomas R. Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with res |
|
| February 13, 2024 |
FHI / Federated Hermes, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0918-federatedhermesinccla.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Federated Hermes, Inc. Class B Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriat |
|
| February 7, 2024 |
PX / P10, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) P10, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 69376K106 (CUSIP Number) January 31, 2024 (Date of Event Which Requires Filing of this Statement) C |
|
| January 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2024 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| January 25, 2024 |
Exhibit 99.1 Federated Hermes, Inc. reports fourth quarter and full-year 2023 earnings •Q4 2023 earnings per diluted share of $0.96; full-year 2023 EPS of $3.40 •Total assets under management at record $757.6 billion •Board declares $0.28 per share quarterly dividend (PITTSBURGH, Pa., Jan. 25, 2024) — Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, today repor |
|
| January 18, 2024 |
SCYX / SCYNEXIS, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292200 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this State |
|
| January 18, 2024 |
RZLT / Rezolute, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) REZOLUTE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76200L309 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statem |
|
| January 18, 2024 |
RGLS / Regulus Therapeutics Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) REGULUS THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 75915K200 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of |
|
| January 18, 2024 |
MRUS / Merus N.V. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) MERUS, N.V. (Name of Issuer) COMMON STOCK (Title of Class of Securities) N5749R100 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement |
|
| January 18, 2024 |
US6033802058 / Minerva Neurosciences Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10*) MINERVA NEUROSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 603380205 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing |
|
| January 18, 2024 |
DVAX / Dynavax Technologies Corporation / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 dvax1568-form.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 23*) DYNAVAX TECHNOLOGIES CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 268158201 (CUSIP Number) December 31, 2023 (Da |
|
| January 18, 2024 |
SSTI / SoundThinking, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 ssti1578-form.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) SOUNDTHINKING, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 82536T107 (CUSIP Number) December 31, 2023 (Date of Event Wh |
|
| January 18, 2024 |
PX / P10, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 px1574-form.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) P10, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 69376K106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires |
|
| January 18, 2024 |
Fusion Networks Holdings, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) FUSION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36118A100 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing |
|
| January 18, 2024 |
LIFE / aTyr Pharma, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7*) ATYR PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 002120202 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Sta |
|
| January 18, 2024 |
IDYA / IDEAYA Biosciences, Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 idya1570-form.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) IDEAYA BIOSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 45166A102 (CUSIP Number) December 31, 2023 (Date of Eve |
|
| January 17, 2024 |
AMPH / Amphastar Pharmaceuticals, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) AMPHASTAR PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03209R103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Fili |
|
| January 17, 2024 |
ARCT / Arcturus Therapeutics Holdings Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ARCTURUS THERAPEUTICS HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03969T109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| December 8, 2023 |
FHI / Federated Hermes Inc - Class B / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Federated Hermes Inc Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: November 30, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
| November 7, 2023 |
MCRB / Seres Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form1418.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) SERES THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81750R102 (CUSIP Number) October 31, 2023 (Date of Event Whi |
|
| October 27, 2023 |
Exhibit 10.3 FEDERATED HERMES, INC. Stock Incentive Plan 2023 RESTRICTED STOCK AWARD AGREEMENT THIS AGREEMENT, is made and effective as of the 17th day of November, 2023 by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania AND «DisplayName», an employee of the Compa |
|
| October 27, 2023 |
Exhibit 10.2 FEDERATED HERMES, INC. STOCK INCENTIVE PLAN (Adopted as of February 20, 1998) (Amended as of August 26, 1998) (Amended as of August 31, 1998) (Amended as of January 26, 1999) (Amended as of May 17, 1999) (Amended as of July 20, 1999) (Amended as of January 29, 2002) (Approved by Shareholders April 24, 2002) (Amended as of February 5, 2004) (Amended as of April 19, 2004) (Amended as of |
|
| October 27, 2023 |
Exhibit 10.4 UK SUB PLAN TO FEDERATED HERMES, INC. STOCK INCENTIVE PLAN (Adopted as of October 25, 2018) (Amended as of January 27, 2022) (Amended as of October 26, 2023) Neither this document, nor any stock award agreement connected with it, is an approved prospectus for the purposes of section 85(1) of the Financial Services and Markets Act 2000 (“FSMA”) and no offer of transferable securities t |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 27, 2023 |
Exhibit 10.5 FEDERATED HERMES, INC. Stock Incentive Plan 2023 RESTRICTED STOCK AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, is made and effective as of the 17th day of November, 2023 by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvan |
|
| October 27, 2023 |
Exhibit 10.1 FEDERATED HERMES, INC. ANNUAL INCENTIVE PLAN Approved by Shareholders April 24, 2002 Amended as of May 13, 2002 Amended as of July 23, 2002 Amended as of February 5, 2004 Amended as of January 25, 2007 Approved by Shareholders April 26, 2012 Approved by Shareholders April 27, 2017 Amended as of February 22, 2019 Amended as of January 31, 2020 Amended as of October 26, 2023 ARTICLE I - |
|
| October 27, 2023 |
Exhibit 10.6 FEDERATED HERMES, INC. Stock Incentive Plan CASH AWARD AGREEMENT FOR AN AWARD TO AN EMPLOYEE THIS AGREEMENT, is made and effective as of the [date] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania AND [Name], an Employee of the Company or a Group Co |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| October 26, 2023 |
Exhibit 99.1 Federated Hermes, Inc. reports third quarter 2023 earnings •Q3 2023 earnings per diluted share of $0.86 •Total assets under management reach a record high of $715.2 billion •Money market assets reach a record $525.1 billion •Board declares $0.28 per share dividend; authorizes new share repurchase program (PITTSBURGH, Pa., Oct. 26, 2023) — Federated Hermes, Inc. (NYSE: FHI), a global l |
|
| September 7, 2023 |
RYTM / Rhythm Pharmaceuticals Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76243J105 (CUSIP Number) August 31, 2023 (Date of Event Which Requires Filing of |
|
| August 8, 2023 |
ANNX / Annexon Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ANNEXON, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03589W102 (CUSIP Number) July 31, 2023 (Date of Event Which Requires Filing of this Statement) |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 27, 2023 |
Exhibit 99.1 Federated Hermes, Inc. reports second quarter 2023 earnings •Q2 2023 earnings per diluted share of $0.81 •Total assets under management reach a record high of $704.0 billion •Money market assets reach a record $509.0 billion •Board declares $0.28 per share dividend (PITTSBURGH, Pa., July 27, 2023) — Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| June 9, 2023 |
MNK / Mallinckrodt Plc - New / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) MALLINCKRODT PLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) G5890A102 (CUSIP Number) May 31, 2023 (Date of Event Which Requires Filing of this Statement |
|
| June 9, 2023 |
Fusion Networks Holdings, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) FUSION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36118A100 (CUSIP Number) May 31, 2023 (Date of Event Which Requires Filing of th |
|
| May 10, 2023 |
RGLS / Regulus Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) REGULUS THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 75915K200 (CUSIP Number) April 30, 2023 (Date of Event Which Requires Filing of th |
|
| May 10, 2023 |
MCRB / Seres Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) SERES THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81750R102 (CUSIP Number) April 30, 2023 (Date of Event Which Requires Filing of this |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| May 2, 2023 |
Federated Hermes Co-Investment Scheme Rules 2023 Adopted by the Board of Directors of FHL on 21 March 2023 1 Contents 1. |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| April 27, 2023 |
Exhibit 99.1 Federated Hermes, Inc. reports first quarter 2023 earnings •Q1 2023 earnings per diluted share of $0.78 •Total assets under management reach all-time high $701.0 billion •Money market assets reach record $505.8 billion •Board declares $0.28 per share dividend, a 4% increase from Q4 2022 (PITTSBURGH, Pa., April 27, 2023) — Federated Hermes, Inc. (NYSE: FHI), a global leader in active, |
|
| April 10, 2023 |
ALBO / Albireo Pharma Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) ALBIREO PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 01345P106 (CUSIP Number) March 31, 2023 (Date of Event Which Requires Filing of this Sta |
|
| April 10, 2023 |
XPOF / Xponential Fitness Inc - Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) XPONENTIAL FITNESS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 98422X101 (CUSIP Number) March 31, 2023 (Date of Event Which Requires Filing of this |
|
| April 10, 2023 |
ORTX / Orchard Therapeutics plc - ADR / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ORCHARD THERAPEUTICS, PLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68570P101 (CUSIP Number) March 31, 2023 (Date of Event Which Requires Filing of thi |
|
| March 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement FEDERATED HERMES, I |
|
| March 10, 2023 |
MRUS / Merus N.V / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) MERUS, N.V. (Name of Issuer) COMMON STOCK (Title of Class of Securities) N5749R100 (CUSIP Number) February 28, 2023 (Date of Event Which Requires Filing of this Statement |
|
| March 10, 2023 |
ARIS / Aris Water Solutions Inc - Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) ARIS WATER SOLUTIONS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04041L106 (CUSIP Number) February 28, 2023 (Date of Event Which Requires Filing of |
|
| February 24, 2023 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 23.01 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-262085, No. 333-224540, No. 333-173859 and No. 333-136081) pertaining to the Federated Hermes, Inc. Stock Incentive Plan and the Registration Statement (Form S-8 No. 333-56429) pertaining to the Federated Hermes, Inc. Employee Stock P |
|
| February 24, 2023 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 31.02 CERTIFICATIONS I, Thomas R. Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with res |
|
| February 24, 2023 |
FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT Exhibit 10.142 EXECUTION COPY FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT This FIRST AMENDMENT TO THE ASSET PURCHASE AGREEMENT (this “Amendment”) is made as of September 30, 2022, by and among FEDERATED HERMES, INC. (“Federated Hermes”), a corporation organized under the laws of the Commonwealth of Pennsylvania, C.W. HENDERSON & ASSOCIATES, INC. (“Seller”), a corporation organized under the laws o |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14818 FEDERATED HERMES, INC. (Ex |
|
| February 24, 2023 |
SIGNIFICANT SUBSIDIARIES OF FEDERATED HERMES, INC.: EXHIBIT 21.01 SIGNIFICANT SUBSIDIARIES OF FEDERATED HERMES, INC.: EMPEF GP Limited, Guernsey company Federated Administrative Services, a Delaware statutory trust Federated Administrative Services, Inc., a Pennsylvania corporation Federated Advisory Services Company, a Delaware statutory trust Federated Asset Management GmbH, a German company (dissolved January 9, 2023) Federated Equity Management |
|
| February 24, 2023 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 31.01 CERTIFICATIONS I, J. Christopher Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 24, 2023 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Federated Hermes, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities a |
|
| February 9, 2023 |
US14757U2087 / CASI Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form878.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) CASI PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 14757U208 (CUSIP Number) January 31, 2023 (Date of Event Wh |
|
| February 9, 2023 |
FHI / Federated Hermes Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Federated Hermes Inc. Class B Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 9, 2023 |
ALEC / Alector Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) ALECTOR, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 014442107 (CUSIP Number) January 31, 2023 (Date of Event Which Requires Filing of this Statemen |
|
| February 9, 2023 |
ANAB / AnaptysBio Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) ANAPTYSBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 032724106 (CUSIP Number) January 31, 2023 (Date of Event Which Requires Filing of this State |
|
| February 1, 2023 |
XPOF / Xponential Fitness, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) XPONENTIAL FITNESS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 98422X101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of t |
|
| February 1, 2023 |
Fusion Networks Holdings, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) FUSION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36118A100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing o |
|
| February 1, 2023 |
SSTI / Shotspotter Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) SHOTSPOTTER, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 82536T107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Sta |
|
| February 1, 2023 |
ORTX / Orchard Therapeutics plc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) ORCHARD THERAPEUTICS, PLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68570P101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of |
|
| February 1, 2023 |
IDYA / Ideaya Biosciences Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) IDEAYA BIOSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 45166A102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of t |
|
| February 1, 2023 |
PX / P10, Inc. Class A Common Stock / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) P10, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 69376K106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) |
|
| February 1, 2023 |
ANNX / Annexon Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) ANNEXON, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03589W102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Stateme |
|
| February 1, 2023 |
AMPH / Amphastar Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) AMPHASTAR PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03209R103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Fili |
|
| February 1, 2023 |
ARIS / Aris Water Solutions, Inc. Class A Common Stock / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form818.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ARIS WATER SOLUTIONS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04041L106 (CUSIP Number) December 31, 2022 (Date of Event W |
|
| February 1, 2023 |
US6033802058 / Minerva Neurosciences Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form824.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9*) MINERVA NEUROSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 603380205 (CUSIP Number) December 31, 2022 (Date of Event |
|
| February 1, 2023 |
ARCT / Arcturus Therapeutics Ltd. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) ARCTURUS THERAPEUTICS HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03969T109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires |
|
| February 1, 2023 |
ALEC / Alector Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) ALECTOR, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 014442107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Stateme |
|
| February 1, 2023 |
DVAX / Dynavax Technologies Corporation / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 22*) DYNAVAX TECHNOLOGIES CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 268158201 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Fi |
|
| February 1, 2023 |
SCYX / SCYNEXIS Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form830.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292200 (CUSIP Number) December 31, 2022 (Date of Event Which Requir |
|
| February 1, 2023 |
ALBO / Albireo Pharma Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form812.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) ALBIREO PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 01345P106 (CUSIP Number) December 31, 2022 (Date of Event Which R |
|
| February 1, 2023 |
MRUS / Merus N.V. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form823.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) MERUS, N.V. (Name of Issuer) COMMON STOCK (Title of Class of Securities) N5749R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires F |
|
| February 1, 2023 |
RZLT / Rezolute Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) REZOLUTE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76200L309 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statem |
|
| February 1, 2023 |
RGLS / Regulus Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form827.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) REGULUS THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 75915K200 (CUSIP Number) December 31, 2022 (Date of Event W |
|
| February 1, 2023 |
IE000O3L0NQ3 / Mallinckrodt PLC / FEDERATED HERMES, INC. Passive Investment SC 13G 1 form811.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) MALLINCKRODT PLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) G5890A102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires |
|
| February 1, 2023 |
MCRB / Seres Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) SERES THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81750R102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of t |
|
| February 1, 2023 |
RYTM / Rhythm Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76243J105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing |
|
| February 1, 2023 |
US14757U2087 / CASI Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) CASI PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 14757U208 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of |
|
| February 1, 2023 |
ANAB / AnaptysBio Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ANAPTYSBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 032724106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Stat |
|
| February 1, 2023 |
LIFE / aTyr Pharma Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6*) ATYR PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 002120202 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Sta |
|
| January 27, 2023 |
Exhibit 99.1 Federated Hermes, Inc. reports fourth quarter and full-year 2022 earnings •Q4 2022 earnings per diluted share of $0.63; full-year 2022 EPS of $2.65, each including a ($0.27) per diluted share non-cash intangible asset impairment charge •Total assets under management at record $668.9 billion •Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., Jan. 26, 2023) — Federated |
|
| January 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2023 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| January 10, 2023 |
RARE / Ultragenyx Pharmaceutical Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form774.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) ULTRAGENYX PHARMACEUTICAL, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 90400D108 (CUSIP Number) December 31, 2022 (Date of Ev |
|
| January 10, 2023 |
OMEG / Omega Alpha SPAC Class A / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form773.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) OMEGA ALPHA SPAC (Name of Issuer) COMMON STOCK (Title of Class of Securities) G6749V107 (CUSIP Number) December 31, 2022 (Date of Event Which Requi |
|
| January 10, 2023 |
AKUS / Akouos Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form772.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) AKOUOS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 00973J101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires |
|
| December 7, 2022 |
BLSA / Bcls Acquisition Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) BCLS ACQUISITION CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) G0904B105 (CUSIP Number) November 30, 2022 (Date of Event Which Requires Filing |
|
| November 9, 2022 |
ARIS / Aris Water Solutions, Inc. Class A Common Stock / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) ARIS WATER SOLUTION, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04041L106 (CUSIP Number) October 31, 2022 (Date of Event Which Requires Filing of t |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| October 27, 2022 |
Exhibit 99.1 Federated Hermes, Inc. reports third quarter 2022 earnings •Q3 2022 earnings per diluted share of $0.78 •Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., Oct. 27, 2022) — Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, today reported earnings per diluted share (EPS) of $0.78 for Q3 2022, compared to $0.73 for the same quarter la |
|
| September 9, 2022 |
CFRX / ContraFect Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8*) CONTRAFECT CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 212326102 (CUSIP Number) August 31, 2022 (Date of Event Which Requires Filing of this |
|
| September 9, 2022 |
OTIC / Otonomy Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6*) OTONOMY, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68906L105 (CUSIP Number) August 31, 2022 (Date of Event Which Requires Filing of this Statement |
|
| September 9, 2022 |
AKUS / Akouos Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) AKOUOS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 00973J101 (CUSIP Number) August 31, 2022 (Date of Event Which Requires Filing of this Statement) |
|
| August 10, 2022 |
DOMO / Domo Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) DOMO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 257554105 (CUSIP Number) July 31, 2022 (Date of Event Which Requires Filing of this Statement) Che |
|
| August 2, 2022 |
Exhibit 10.1 Execution Version ASSET PURCHASE AGREEMENT Among FEDERATED HERMES, INC., C.W. HENDERSON & ASSOCIATES, INC., And THE OWNERS IDENTIFIED HEREIN Dated as of July 15, 2022 312419107.19 TABLE OF CONTENTS Page SECTION 1. DEFINITIONS 2 1.1 Certain Definitions 2 1.2 Construction 18 SECTION 2. PURCHASE AND SALE OF ASSETS 18 2.1 Sale and Purchase of the Acquired Assets 18 2.2 Retained Assets 20 |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001 |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| July 28, 2022 |
Exhibit 99.1 Federated Hermes, Inc. reports second quarter 2022 earnings ?Q2 2022 earnings per diluted share of $0.64 ?Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., July 28, 2022) ? Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, today reported earnings per diluted share (EPS) of $0.64 for Q2 2022, compared to $0.56 for the same quarter l |
|
| July 18, 2022 |
Exhibit 99.1 Federated Hermes, Inc. agrees to acquire the $3.63 billion investment advisory business of C.W. Henderson, a specialist in municipal-bond separately managed accounts ? Entire team to join Federated Hermes and continue managing portfolios (PITTSBURGH, Pa., July 18, 2022) ? Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, reached a definitive agreeme |
|
| July 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I. |
|
| July 11, 2022 |
MCRB / Seres Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) SERES THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81750R102 (CUSIP Number) June 30, 2022 (Date of Event Which Requires Filing of this |
|
| June 10, 2022 |
SSTI / Shotspotter Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) SHOTSPOTTER, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 82536T107 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of this Statemen |
|
| June 10, 2022 |
FREQ / Frequency Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) FREQUENCY THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 35803L108 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of th |
|
| June 10, 2022 |
GMDA / Gamida Cell Ltd / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) GAMIDA CELL LTD. (Name of Issuer) COMMON STOCK (Title of Class of Securities) M47364100 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of this Statement |
|
| June 10, 2022 |
STEP / StepStone Group Inc. Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) STEPSTONE GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 85914M107 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of this Stat |
|
| June 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I.R |
|
| May 16, 2022 |
RGLS / Regulus Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) REGULUS THERAPEUTICS INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 75915K200 (CUSIP Number) April 30, 2022 (Date of Event Which Requires Filing of this |
|
| May 10, 2022 |
AVRO / Avrobio Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) AVROBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 05455M100 (CUSIP Number) April 30, 2022 (Date of Event Which Requires Filing of this Statement) |
|
| May 10, 2022 |
ANAB / AnaptysBio Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form241.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) ANAPTYBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 032724106 (CUSIP Number) April 30, 2022 (Date of Event Which Requires |
|
| May 3, 2022 |
Exhibit 10.1 Execution Version Federated Hermes, Inc. $350,000,000 3.29% Senior Notes due March 17, 2032 Note Purchase Agreement Dated March 17, 2022 Note Purchase Agreement ? Federated Hermes Table of Contents Section Heading Page Section 1. Authorization of Notes 1 Section 2. Sale and Purchase of Notes 1 Section 2.1. The Notes 1 Section 2.2. Subsidiary Guaranties 1 Section 3. Closing 2 Section 4 |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00 |
|
| April 28, 2022 |
Exhibit 99.1 Federated Hermes, Inc. reports first quarter 2022 earnings ?Q1 2022 earnings per diluted share of $0.61 ?Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., April 28, 2022) ? Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, today reported earnings per diluted share (EPS) of $0.61 for Q1 2022, compared to $0.75 for the same quarter l |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| April 11, 2022 |
BZUN / Baozun Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6*) BAOZUN, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 06684L103 (CUSIP Number) March 31, 2022 (Date of Event Which Requires Filing of this Statement) |
|
| April 11, 2022 |
RYTM / Rhythm Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 rhythm.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76243J105 (CUSIP Number) March 31, 2022 (Date of Event Whic |
|
| March 17, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| March 16, 2022 |
DEF 14C 1 d671334ddef14c.htm DEF 14C - INFORMATION STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) (I |
|
| March 9, 2022 |
FHI / Federated Hermes Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Federated Hermes Inc. Class B Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: February 28, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14818 FEDERATED HERMES, INC. (Ex |
|
| February 25, 2022 |
Exhibit 10.139 Pool A and Pool B Awards ? Retiring Employee FEDERATED HERMES, INC. Stock Incentive Plan RESTRICTED STOCK AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, is made and effective as of [Date] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pitt |
|
| February 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 23.01 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-262085, No. 333-224540, No. 333-173859 and No. 333-136081) pertaining to the Federated Hermes, Inc. Stock Incentive Plan and the Registration Statement (Form S-8 No. 333-56429) pertaining to the Federated Hermes, Inc. Employee Stock P |
|
| February 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 31.01 CERTIFICATIONS I, J. Christopher Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 25, 2022 |
Exhibit 10.137 Pool A Awards FEDERATED HERMES, INC. Stock Incentive Plan RESTRICTED STOCK AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, is made and effective as of [date] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania A N D Herm |
|
| February 25, 2022 |
SIGNIFICANT SUBSIDIARIES OF FEDERATED HERMES, INC.: EXHIBIT 21.01 SIGNIFICANT SUBSIDIARIES OF FEDERATED HERMES, INC.: EMPEF GP Limited Federated Administrative Services, a Delaware statutory trust Federated Administrative Services, Inc., a Pennsylvania corporation Federated Advisory Services Company, a Delaware statutory trust Federated Equity Management Company of Pennsylvania, Delaware statutory trust Federated Global Holdings LLC, a Delaware lim |
|
| February 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Federated Hermes, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities a |
|
| February 25, 2022 |
Exhibit 10.138 Pool A Awards - Singapore FEDERATED HERMES, INC. Stock Incentive Plan RESTRICTED STOCK AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN SINGAPORE THIS AGREEMENT, is made and effective as of [date] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania A N D H |
|
| February 25, 2022 |
Exhibit 10.136 Pool A and Pool B Awards FEDERATED HERMES, INC. Stock Incentive Plan RESTRICTED STOCK AWARD AGREEMENT FOR AWARDS TO EMPLOYEES IN THE UNITED KINGDOM THIS AGREEMENT, is made and effective as of [date] by and between Federated Hermes, Inc. (including its successors and assigns, the "Company"), a Pennsylvania corporation having its principal place of business in Pittsburgh, Pennsylvania |
|
| February 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EXHIBIT 31.02 CERTIFICATIONS I, Thomas R. Donahue, certify that: 1.I have reviewed this annual report on Form 10-K of Federated Hermes, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with res |
|
| February 25, 2022 |
UK SUB PLAN TO FEDERATED HERMES, INC. STOCK INCENTIVE PLAN (Amended as of January 27, 2022) Exhibit 10.135 UK SUB PLAN TO FEDERATED HERMES, INC. STOCK INCENTIVE PLAN (Amended as of January 27, 2022) Neither this document, nor any stock award agreement connected with it, is an approved prospectus for the purposes of section 85(1) of the Financial Services and Markets Act 2000 (?FSMA?) and no offer of transferable securities to the public (for the purposes of section 102B of FSMA) is being |
|
| February 14, 2022 |
ANNX / Annexon Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) ANNEXON, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03589W102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statemen |
|
| February 14, 2022 |
AKUS / Akouos Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 akus48.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) AKOUOS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 00973J101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires F |
|
| February 14, 2022 |
CFRX / ContraFect Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7*) CONTRAFECT CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 212326102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of thi |
|
| February 14, 2022 |
DVAX / Dynavax Technologies Corporation / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21*) DYNAVAX TECHNOLOGIES CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 268158201 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Fi |
|
| February 14, 2022 |
AMPH / Amphastar Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) CASI PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03209R103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of |
|
| February 14, 2022 |
AMPH / Amphastar Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) AMPHASTAR PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03209R103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Fili |
|
| February 14, 2022 |
BRZE / Braze Inc - Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) BRAZE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 10576N102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) |
|
| February 14, 2022 |
ARCT / Arcturus Therapeutics Ltd. / FEDERATED HERMES, INC. Passive Investment SC 13G 1 form37.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) ARCTURUS THERAPEUTICS HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03969T109 (CUSIP Number) December 31, 2021 (Date of E |
|
| February 14, 2022 |
OTIC / Otonomy Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) OTONOMY, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68906L105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Stateme |
|
| February 14, 2022 |
AVRO / Avrobio Inc / FEDERATED HERMES, INC. Passive Investment SC 13G 1 form40.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) AVROBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 05455M100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Fil |
|
| February 14, 2022 |
LIFE / aTyr Pharma Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) ATYR PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 002120103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Sta |
|
| February 14, 2022 |
IDYA / Ideaya Biosciences Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) IDEAYA BIOSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 45166A102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of th |
|
| February 14, 2022 |
XPOF / Xponential Fitness, Inc. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) XPONENTIAL FITNESS INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 98422X101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of thi |
|
| February 14, 2022 |
GMDA / Gamida Cell Ltd / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) GAMIDA CELL LTD. (Name of Issuer) COMMON STOCK (Title of Class of Securities) M47364100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Stat |
|
| February 14, 2022 |
RYTM / Rhythm Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76243J105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing o |
|
| February 14, 2022 |
NERV / Minerva Neurosciences Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8*) MINERVA NEUROSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 603380106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing o |
|
| February 14, 2022 |
RNA / Prosensa Holding N.v. In Liquidatie / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) AVIDITY BIOSCIENCES LLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 05370A108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of thi |
|
| February 14, 2022 |
DOMO / Domo Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) DOMO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 257554105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) |
|
| February 14, 2022 |
SSTI / Shotspotter Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form67.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) SHOTSPOTTER, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 82536T107 (CUSIP Number) December 31, 2021 (Date of Event Which Requi |
|
| February 14, 2022 |
RARE / Ultragenyx Pharmaceutical Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form69.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) ULTRAGENYX PHARMACEUTICAL, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 90400D108 (CUSIP Number) December 31, 2021 (Date of Eve |
|
| February 14, 2022 |
PX / P10, Inc. Class A Common Stock / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form63.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) P10, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 69376K106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Fili |
|
| February 14, 2022 |
MRUS / Merus N.V. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) MERUS, N.V. (Name of Issuer) COMMON STOCK (Title of Class of Securities) N5749R100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement |
|
| February 14, 2022 |
BLSA / Bcls Acquisition Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) BCLS ACQUISITION CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) G0904B105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing |
|
| February 14, 2022 |
FREQ / Frequency Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) FREQUENCY THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 35803L108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing |
|
| February 14, 2022 |
ALBO / Albireo Pharma Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 alec50.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) ALECTOR, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 01345P106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires |
|
| February 14, 2022 |
SCYX / SCYNEXIS Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statem |
|
| February 14, 2022 |
ARIS / Aris Water Solutions, Inc. Class A Common Stock / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) ARIS WATER SOLUTION, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 04041L106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of t |
|
| February 14, 2022 |
OMEG / Omega Alpha SPAC Class A / FEDERATED HERMES, INC. Passive Investment SC 13G 1 form44.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) OMEGA ALPHA SPAC (Name of Issuer) COMMON STOCK (Title of Class of Securities) G6749V107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires |
|
| February 14, 2022 |
ANAB / AnaptysBio Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) ANAPTYBIO, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 032724106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statem |
|
| February 14, 2022 |
STEP / StepStone Group Inc. Class A / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form68.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) STEPSTONE GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 85914M107 (CUSIP Number) December 31, 2021 (Date of Event Which R |
|
| February 14, 2022 |
RZLT / Rezolute Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) REZOLUTE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76200L309 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statem |
|
| February 14, 2022 |
MCRB / Seres Therapeutics Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) SERES THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81750R102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of th |
|
| February 14, 2022 |
ORTX / Orchard Therapeutics plc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) ORCHARD THERAPEUTICS, PLC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68570P101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of t |
|
| February 14, 2022 |
BZUN / Baozun Inc. / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 bzun575.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5*) BAOZUN, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 06684L103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires |
|
| February 14, 2022 |
ALBO / Albireo Pharma Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3*) ALBIREO PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 01345P106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this |
|
| February 10, 2022 |
IMXI / International Money Express Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) INTERNATIONAL MONEY EXPRESS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46005L101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Fi |
|
| February 10, 2022 |
FHI / Federated Hermes Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Federated Hermes Inc. Class B Title of Class of Securities: Common Stock CUSIP Number: 314211103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 10, 2022 |
IMXI / International Money Express Inc / FEDERATED HERMES, INC. Passive Investment SC 13G/A 1 form273.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) INTERNATIONAL MONEY EXPRESS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46005L101 (CUSIP Number) January 31, 2022 (Date of E |
|
| January 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| January 27, 2022 |
Exhibit 99.1 Federated Hermes, Inc. reports fourth quarter and full-year 2021 earnings ?Q4 2021 earnings per diluted share of $0.71; full-year 2021 EPS of $2.75 ?Total assets under management reach a record $668.9 billion ?Long-term assets reach a record $221.0 billion ?Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., Jan. 27, 2022) ? Federated Hermes, Inc. (NYSE: FHI), a global |
|
| January 10, 2022 |
As filed with the Securities and Exchange Commission on January 10, 2022 As filed with the Securities and Exchange Commission on January 10, 2022 Registration No. |
|
| January 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2022 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) ( |
|
| January 7, 2022 |
Exhibit 10.1 FEDERATED HERMES, INC. STOCK INCENTIVE PLAN (Adopted as of February 20, 1998) (Amended as of August 26, 1998) (Amended as of August 31, 1998) (Amended as of January 26, 1999) (Amended as of May 17, 1999) (Amended as of July 20, 1999) (Amended as of January 29, 2002) (Approved by Shareholders April 24, 2002) (Amended as of February 5, 2004) (Amended as of April 19, 2004) (Amended as of |
|
| December 17, 2021 |
DEF 14C 1 d235008ddef14c.htm DEF 14C - INFORMATION STATEMENT FEDERATED HERMES, INC. Federated Hermes Tower Pittsburgh, Pennsylvania 15222-3779 INFORMATION STATEMENT December 17, 2021 INTRODUCTION This Information Statement is furnished to the shareholders (the “Shareholders”) of Federated Hermes, Inc. (“Federated Hermes” or the “Company”) by its Board of Directors (“Board”) in connection with obta |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2021 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| December 10, 2021 |
CALA / Calithera Biosciences Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) CALITHERA BIOSCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 13089P101 (CUSIP Number) November 30, 2021 (Date of Event Which Requires Filing o |
|
| December 10, 2021 |
SCYX / SCYNEXIS Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8*) SCYNEXIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 811292101 (CUSIP Number) November 30, 2021 (Date of Event Which Requires Filing of this Statem |
|
| December 10, 2021 |
QRHC / Quest Resource Holding Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) QUEST RESOURCE HOLDING CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 74836W203 (CUSIP Number) November 30, 2021 (Date of Event Which Requires Filing |
|
| December 10, 2021 |
RYTM / Rhythm Pharmaceuticals Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76243J105 (CUSIP Number) November 30, 2021 (Date of Event Which Requires Filing o |
|
| November 10, 2021 |
OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) P10, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 69376K106 (CUSIP Number) October 31, 2021 (Date of Event Which Requires Filing of this Statement) Ch |
|
| November 10, 2021 |
RZLT / Rezolute Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2*) REZOLUTE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 76200L309 (CUSIP Number) October 31, 2021 (Date of Event Which Requires Filing of this Stateme |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 28, 2021 |
Exhibit 99.1 Federated Hermes, Inc. reports third quarter 2021 earnings ?Fixed-income assets reach a record $97 billion ?Long-term assets reach a record $220 billion ?Board declares $0.27 per share quarterly dividend (PITTSBURGH, Pa., Oct. 28, 2021) ? Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, today reported earnings per diluted share (EPS) of $0.73 for Q |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 FEDERATED HERMES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 001-14818 25-1111467 (State or other jurisdiction (Commission File Number) |
|
| October 8, 2021 |
MX / Magnachip Semiconductor Corp / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) MAGNACHIP SEMICONDUCTOR CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 55933J203 (CUSIP Number) September 30, 2021 (Date of Event Which Requires |
|
| October 8, 2021 |
LIFE / aTyr Pharma Inc / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4*) ATYR PHARMA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 002120103 (CUSIP Number) September 30, 2021 (Date of Event Which Requires Filing of this St |
|
| October 8, 2021 |
STEP / StepStone Group Inc. Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) STEPSTONE GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 85914M107 (CUSIP Number) September 30, 2021 (Date of Event Which Requires Filing of thi |
|
| October 8, 2021 |
GDYN / Grid Dynamics Holdings, Inc. Class A / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ?.11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1*) GRID DYNAMICS HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 39813G109 (CUSIP Number) September 30, 2021 (Date of Event Which Requires Filing |
